2016 January 24

Dr. Albert Oriol publishes a new article

Dr. Albert Oriol publishes a new article on improving treatment for patients with multiple myeloma in The Lancet

Daratumumab has been tested by an international team that includes Dr.Oriol, together with colleagues from the United States and Canada, to discover a combination which will delay relapse in those patients with multiple myeloma who do not respond to established treatments and for whom a transplant would not be considered appropriate. The trial, which was conducted with 157 patients, improved both the time of response and tolerance to treatment.

For more information the paper can be found here:
http://www.ncbi.nlm.nih.gov/pubmed/?term=Daratumumab+monotherapy+in+patients+with+treatment-refractory+multiple+myeloma+%28SIRIUS%29%3A+an+open-label%2C+randomised%2C+phase+2+trial